Meet with... Canaan Partners

Feb 12 2015

JLABS BOSTON EVENT How are you impacting medicine?
Canaan Partners is a global venture capital firm that invests in entrepreneurs with visionary ideas. With $4.2 billion under management and over 160 exits to date, Canaan has funded some of the world's leading technology companies including LendingClub, Ebates, PrimeSense, and Skybox Imaging as well as healthcare stars like Chimerix, Durata, Labrys Biologics, and Civitas Therapeutics. Canaan recently announced Fund X, a $675 million fund focused on early stage IT and healthcare startups. The fund's healthcare focus includes biopharma, medical devices, and digital health.

Julie Papanek, Principal at Canaan Partners, will be in attendance on February 12th to provide an overview presentation of Canaan's areas of interest and best practices when applying for funding. Julie will be on hand to meet with a handful of applicants one-on-one after the presentation. To be considered for a one-on-one meeting, complete the information required here.

10:30am | Registration and Networking
11:00am | Presentation and Q&A
11:45am | Networking Lunch
12:30-4:00pm | One-on-one Meetings*

*Companies must have applied for a one-on-one meeting ahead of time and be approved. The application period ends on January 26th.

Canaan Partners Participating Representative:
Julie Papanek | Principal, Canaan Partners read bio»

About Canaan Partners:
Canaan Partners is a global venture capital firm that invests in people with visionary ideas. The kind that not only result in new and valuable technology, but game-changing healthcare startups as well. We were early investors in some of the world's leading technology companies, including PrimeSense, SuccessFactors and LendingClub and healthcare stars like Cerexa, Chimerix and Advanced BioHealing. All of which makes one thing perfectly clear. When people are your priority, good things happen.

Presentation & Lunch
$25 | General Public
$35 | General Public Onsite
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Registration to attend the presentation, Q&A, and lunch will remain open until February 11th (or sold out).

One-on-One Meeting
FREE | Application
FREE | Accepted Companies
Companies must have applied for a one-on-one meeting ahead of time. The one-on-one application period ends on January 26th. Your application will be reviewed and you will be notified of acceptance by February 2nd, 2015. Acceptance of a one-on-one meeting is not guaranteed as all applications must be approved.

JLABS @LabCentral
700 Main St
Cambridge, MA 02139

Canaan Partners Representative's Biography:
Julie Papanek Julie Papanek | Principal, Canaan Partners
If it looks challenging, it's a "maybe." If it's for a good cause, it's a "probably." If it looks really challenging and it's for a good cause, you can clear Julie Papanek's calendar. Julie biked 4000 miles across the country to raise money for Habitat for Humanity, and has competed in triathlons to benefit the Leukemia and Lymphoma Society. It's no secret that Julie takes the same approach when investing. Better startups just aren't enough... she wants better patient outcomes.
Julie brings operational experience from biotechnology and healthIT. Prior to Canaan, Julie worked at Genentech in a variety of positions spanning marketing, development, and business development. This included creating commercial brand plans, forecasting, and recommending modifications to Phase III trials designs for marketed and pipeline oncology products. Recently, she interned at Proteus Digital Health, identifying market opportunities for their digital health platform and generating business development leads. Julie also worked in Bangalore, implementing the pilot electronic medical record system at Narayana Hrudayalaya, one of India's largest multispecialty hospital chains.
Julie holds an MBA from Stanford's Graduate School of Business, where she was the teaching assistant for the Biodesign Innovation course and an officer of the Healthcare Club. Previously, she earned an MPhil from Cambridge University in BioScience Enterprise and a B.S. from Yale University in Molecular Biophysics and Biochemistry.

Julie's Favorite Things: "High adrenaline sports. Observers may yell 'yard sale!' when I ski, and I may spend more time under the water than above it when I kiteboard, but I keep coming back for more."
Connect with Julie: Connect on LinkedIn Connect on Twitter  

About the Meet with... Series:
The purpose of the Meet with Series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, MedImmune Ventures, NCI, Mercury Fund, Correlation Ventures, Breakout Labs, New Enterprise Associates, Thomas McNerney & Partners, NCATS, Poliwogg, and OrbiMed.